CompletedNot Applicable

the Effect of Transcutaneous Electrical Acupoint Stimulation on the Quality of Oocyte on Poor Ovarian Response(POR)

China92 participantsStarted 2020-01-01

Plain-language summary

Patients in experimental group will be given transcutaneous electrical acupoint stimulation (TEAS) treatment for 12 weeks prior to controlled ovarian stimulation (COS).The patients will be given three times acupuncture every week except menstruation.Patients in no intervention group will not be given any interventions for 12 weeks prior to COS. The primary outcome measure is the number of MII eggs obtained in the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes.

Who can participate

Age range20 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The poor ovarian response patients compliance with Bologna consensus
✓. Age：20-45 year
✓. Women undergoing IVF-ET because of infertility for more than one year.

Exclusion criteria

✕. Patients with genital tract malformation. Uterine malformation (single uterus, double uterus, double uterus, untreated mediastinal uterus) and other effects affecting uterine cavity disease (adenomyosis, submucosal uterine fibroids, intrauterine adhesions and scar uterus)
✕. Complicated with other medical diseases（Hypertension, diabetes, psychosis, hereditary diseases）

What they're measuring

The number of MII eggs

Timeframe: one day after oocyte pickup

Trial details

NCT IDNCT03994614

SponsorShangHai Ji Ai Genetics & IVF Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-05-01

View on ClinicalTrials.gov More Poor Ovarian Response trials